Cannabidiol (CBD, Epidiolex) a derivative of the active ingredient in Cannabis sativa has been demonstrated to be effective in reducing the frequency of seizures in children and young adults for whom conventional treatment was ineffective. A year-long trial of the compound showed this "medical marijuana" to be well-tolerated and safe. Orrin Devinsky, director of the Comprehensive Epilepsy Center at New York University Langone, and colleagues published details of their findings in the journal Lancet Neurology. "We are very encouraged by our trial results," says Devinsky. "But before we raise hopes for families who regularly deal with the devastation of treatment-resistant epilepsy, more research [is] needed to definitively recommend CBD as a treatment to patients with uncontrolled seizures."
Seizing on medical marijuana